Coagulation factor VII and Tissue factor complex (FVIIa/TF)

The Coagulation factor VII and Tissue factor complex, also known as the extrinsic tenase complex, is the primary initiator of the blood coagulation cascade in vivo (NIH, 1997; Wikipedia, 2024). It consists of the serine protease Factor VIIa (FVIIa) and its essential integral membrane protein cofactor, Tissue Factor (TF), which is typically sequestered from the blood until vascular injury occurs (NIH, 2008; NIH, 2009). Upon exposure, TF binds FVIIa with high affinity, allosterically enhancing its catalytic activity by several orders of magnitude to activate Factor X and Factor IX (NIH, 2008; NIH, 2017). Beyond its critical role in hemostasis, the complex mediates cellular signaling through the cleavage of protease-activated receptor 2 (PAR2), influencing processes such as inflammation, angiogenesis, and tumor progression (NIH, 2009; NIH, 2017). Therapeutically, recombinant FVIIa is used as a bypassing agent to treat bleeding in hemophilia patients with inhibitors, while inhibitors of the complex are being investigated for their potential as anticoagulants and anti-cancer agents (NIH, 2008; Wikipedia, 2024). However, targeting this complex requires careful management of the balance between preventing thrombosis and maintaining adequate hemostasis to avoid life-threatening bleeding or clotting events (NIH, 2009; ResearchGate, 2006).

Other names

Extrinsic tenase complexTissue factor-Factor VIIa complexCoagulation factor III and VIIa complexThromboplastin-Factor VIIa complex

Initiation of the extrinsic pathway of coagulation through the proteolytic activation of Factor X and Factor IX; induction of intracellular signaling via cleavage of protease-activated receptor 2 (PAR2).